Hepatitis C Virus: Containing the Threat

Comments

Transcript

About this Series

In the past few years, a new class of direct-acting antiviral agents has made the treatment of HCV easier and more effective than ever before, with cure rates nearing 100%, even among HIV-positive patients.

But not all patients with HCV who are eligible for antiviral treatment are identified, and even fewer are being referred for care. Thus, HCV infection remains a significant risk for progression to cirrhosis, liver failure, and hepatocellular carcinoma.

Liver specialists at two prestigious Chicago medical centers confront the key issues in the management of patients with chronic HCV infection.

Who's Who

●●●

{{{title}}}

{{{name}}} {{{addComma prof}}}

{{{desc}}}

{{#if disclosureTitle }} Disclosure

Disclosure

{{{disclosureTitle}}}

{{{disclosureText}}}